Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 06-12-2013 | Practice Area: | Equity Capital Markets |
| Deal Title: | Xencor, Inc NASDAQ Initial Public Offering | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk advised Credit Suisse Securities (USA) LLC and Leerink Swann LLC as joint book-running managers in connection with the USD80.5 million initial public offering of common stock of Xencor, Inc. The common stock is listed on the Nasdaq Global Market under the symbol XNCR.
Based in Monrovia, California, Xencor, Inc. is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer.
The Davis Polk corporate team included partner Bruce Dallas and associates Jason Bassetti and Adam Gottesfeld. The tax team included partner Harry Ballan and associate Catherine Paskoff Chang. The intellectual property team included associates Bruce Rose-Innes and Julian Russo. Counsel Cynthia Akard and Marcie A. Goldstein provided executive compensation and FINRA advice, respectively. Kimberly Kakade and Katie Young were the legal assistants on the transaction. Members of the Davis Polk team are based in the Menlo Park and New York offices.
|
||
| Financial Center: | Silicon Valley | Value: | 0.00-100.00 |
| Advised Party: | Lead Managers | Law Firm | Davis Polk |
| Issuer Jurisdiction- | United States | Listing Jurisdiction- | United States |
| Classification: |
Initial Public Offerings NASDAQ |
Lawyer | Bruce K Dallas |
